Cellect Biotechnology (APOP) Stock: Rocketing On Clinical Results
Cellect Biotechnology Ltd. (NASDAQ: APOP) is making a run for the top in the market this morning, and for good reason. The company announced clinical results, exciting investors and sending the stock running for the top. Today, we’ll talk about: The clinical results; what we’re seeing from APOP stock as a result; and what we’ll … Read more